Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
Affiliations: Cancer Vaccine Center, Kurume University, Kurume, Fukuoka 839‑0823, Japan, Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan, Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka 830-0011, Japan, Cancer Vaccine and Immunotherapy Center, Kanagawa Cancer Center Research Institute, Kanagawa, Yokohama 241‑8515, Japan, Department of Gastroenterological Surgery, Fukuoka University School of Medicine, Fukuoka 814‑0180, Japan
- Published online on: December 29, 2020 https://doi.org/10.3892/mco.2020.2201
- Article Number: 39
Copyright: © Uchino et al. This is an open access article distributed under the terms of Creative Commons Attribution License.